Epilepsy Symposium Speaker Bios
We are thrilled to announce Professor Mark Cook will be presenting on the topic of ‘Seizure detection and prediction: New technologies.” As Chair of Medicine at St Vincent’s Hospital, and previously the Director of Neurology, Prof Cook is highly regarded locally and internationally for his expertise in epilepsy management, particularly imaging and surgical planning.
Professor Cook is also the brains behind the Epi-Minder implant which has featured on A Current Affair.
This incredible innovation is by Prof Cook and his team is bringing hope to people with epilepsy by capturing data that can forecast seizures based on a person’s individual patterns.
Associate Professor Lata Vadlamudi is a Senior Staff Specialist in Neurology at the Royal Brisbane and Women’s Hospital; Epileptologist within the Comprehensive Epilepsy Program; Metro North Clinician Research Fellow; and Neurosciences Theme Leader at the University of Queensland Centre for Clinical Research.
Clinical interests include integrating genomics into clinical care and management of women with epilepsy, in particular during pregnancy. Current research projects include developing patient-specific organoid models to personalise epilepsy care and a current MRFF-funded stem cell therapies PERSIST mission.
Prof Dunne is the Clinical Professor of the Department of Medicine at the University of Western Australia. He serves as Chairman of the Western Australian Comprehensive Epilepsy Service and as Secretary General for International League Against Epilepsy (ILAE) – Asia Oceania. A member and past chairman (2015-2019) of the Asian Epilepsy Academy (ASEPA), ILAE, Prof Dunne has been involved in epilepsy and clinical neurophysiology teaching throughout the Asian and Oceanian region. The esteemed neurologist is also a member of Epilepsy Society of Australia national executive and participates in EEG, driving and other committees.
Dr Gillinder is a neurologist and epileptologist and specialises in stereo-electroencephalography (SEEG) and the surgical management of epilepsy. She has a strong research focus and is the lead of the Mater epilepsy research program. Her clinical studies are centred around improving epilepsy diagnostics and her pivotal work is investigating a link between seizure semiology and autoimmunity.
Dr Alex Lehn is a neurologist who set up a dedicated clinic for FND at the Mater Hospital, the first of its kind in Australia, and has extensive knowledge on the topic of movement disorders.
Mr Vince Cheah is a Nurse Navigator and began his career at the Mater Centre for Neurosciences. Vince currently works with the Metro South Movement Disorder Team where he works closely with the Brisbane FND team to deliver nationwide education, develop open source FND resources and promote the QLD FND special interest group across the QLD Hospital Health Services.
Dr Carter is a health economist and Senior Research Fellow at Australian Centre for Health Services Innovation (AusHSI) at the Queensland University of Technology. Focusing on embedding economic evaluation in health services research, Dr Carter’s work aims to improve the efficiency and sustainability of the health system.
A/Prof Crompton is Head of Neurology at Northern Health, Melbourne. His major research interests are in the genetics of focal epilepsies and Sudden Unexpected Death in Epilepsy. He is a passionate clinical teacher, and member of the Melbourne Academy of Clinical Teachers.
A/Prof Crompton began his career in the field of genetics, completing his PhD in Drosophila molecular biology before going to medical school in Newcastle upon Tyne, UK. He completed his core medical training and commenced his specialty training in Neurology in the north East of England before making the inspired decision to relocate to Melbourne. He has led the Northern Health Neurology service since 2012 and has overseen its enormous growth in volume and complexity.
Prof Wolvetang is a senior group leader at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland (Australia) where he leads a research team that employs human induced pluripotent stem cell derived brain organoids as in vitro disease models for monogenic and complex neurological diseases.
Leveraging these “human brain in a dish” models he aims to understand how genetic mutations cause diseases that affect the brain during development and later in life, and to identify and test therapeutic approaches that can improve patient health outcomes.